Exchange Capital Management, Inc. Neuro Bo Pharmaceuticals, Inc. Transaction History

Exchange Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$5.41 - $8.67 $60,294 - $96,627	-11,145 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$8.05 - $29.44 $69,085 - $252,654	-8,582 Reduced 43.5%	11,145 $90,000
Q1 2020 Apr 28, 2020	SELL	$7.24 - $30.0 $173 - $720	-24 Reduced 0.12%	19,727 $274,000
Q4 2019 Jan 29, 2020	BUY	$6.83 - $9.9 $134,899 - $195,534	19,751 New	19,751 $173,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Exchange Capital Management, Inc. with notifications on news.